Dr. Ifeoma Aduba, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,561 | 128 | 96.6% |
| Education | $89.00 | 1 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $414.72 | 16 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $411.30 | 16 | $0 (2024) |
| Astellas Pharma US Inc | $350.47 | 15 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $228.28 | 8 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $209.69 | 13 | $0 (2020) |
| PFIZER INC. | $186.56 | 14 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $181.13 | 8 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $157.46 | 10 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $92.46 | 7 | $0 (2020) |
| Shionogi Inc | $75.47 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $144.14 | 2 | Janssen Pharmaceuticals, Inc ($123.77) |
| 2023 | $43.60 | 2 | Janssen Pharmaceuticals, Inc ($43.60) |
| 2022 | $179.87 | 8 | Shionogi Inc ($55.10) |
| 2021 | $241.08 | 8 | Astellas Pharma US Inc ($154.86) |
| 2020 | $196.01 | 12 | PFIZER INC. ($39.34) |
| 2019 | $757.90 | 39 | Merck Sharp & Dohme Corporation ($177.54) |
| 2018 | $899.74 | 46 | Merck Sharp & Dohme Corporation ($203.78) |
| 2017 | $187.29 | 12 | SANOFI-AVENTIS U.S. LLC ($39.93) |
All Payment Transactions
129 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/08/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Infections and Infectious Diseases | ||||||
| 02/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $123.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/25/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/29/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/26/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/11/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/21/2022 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $30.69 | General |
| Category: Infections and Infectious Diseases | ||||||
| 04/26/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/14/2022 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Infections and Infectious Diseases | ||||||
| 04/11/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA, RECARBRIO | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/04/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), RELISTOR | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Gastroenterology | ||||||
| 02/04/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/27/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $89.00 | General |
| 06/25/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $30.74 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/23/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Gastroenterology | ||||||
| 05/20/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Gastroenterology | ||||||
| 04/23/2021 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: HOSPITAL AND TRANSPLANT | ||||||
| 04/13/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/17/2021 | Astellas Pharma US Inc | AMBISOME (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: HOSPITAL AND TRANSPLANT | ||||||
| 03/01/2021 | Astellas Pharma US Inc | LEXISCAN (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: HOSPITAL AND TRANSPLANT | ||||||
| 11/16/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: DIABETES | ||||||
| 11/12/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/02/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), RELISTOR | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/10/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/28/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 368 | 712 | $172,244 | $52,885 |
| 2022 | 7 | 414 | 769 | $134,480 | $53,385 |
| 2021 | 4 | 298 | 518 | $70,310 | $36,709 |
| 2020 | 4 | 400 | 760 | $110,730 | $56,370 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 130 | 346 | $64,422 | $19,623 | 30.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 57 | 179 | $47,915 | $16,232 | 33.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 110 | 116 | $31,912 | $9,798 | 30.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 32 | 32 | $16,559 | $4,416 | 26.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 25 | 25 | $8,806 | $2,013 | 22.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 14 | 14 | $2,630 | $804.08 | 30.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 172 | 400 | $54,472 | $21,697 | 39.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 81 | 203 | $39,372 | $16,200 | 41.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 92 | 93 | $20,939 | $7,543 | 36.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 30 | 31 | $11,385 | $5,127 | 45.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 13 | 13 | $3,179 | $1,338 | 42.1% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 12 | 15 | $2,718 | $874.30 | 32.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 14 | 14 | $2,416 | $605.30 | 25.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 172 | 360 | $41,400 | $21,741 | 52.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 60 | 92 | $14,720 | $8,068 | 54.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 55 | 55 | $10,725 | $4,874 | 45.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 11 | 11 | $3,465 | $2,027 | 58.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 185 | 463 | $53,245 | $27,401 | 51.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 90 | 170 | $27,200 | $14,629 | 53.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 45 | 46 | $14,490 | $7,476 | 51.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 80 | 81 | $15,795 | $6,865 | 43.5% |
About Dr. Ifeoma Aduba, M.D
Dr. Ifeoma Aduba, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2014. The National Provider Identifier (NPI) number assigned to this provider is 1578983003.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ifeoma Aduba, M.D has received a total of $2,650 in payments from pharmaceutical and medical device companies, with $144.14 received in 2024. These payments were reported across 129 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,561).
As a Medicare-enrolled provider, Aduba has provided services to 1,480 Medicare beneficiaries, totaling 2,759 services with total Medicare billing of $199,350. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Internal Medicine
- Location Dallas, TX
- Active Since 04/23/2014
- Last Updated 02/13/2023
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1578983003
Products in Payments
- XARELTO (Drug) $411.30
- ZERBAXA (Drug) $280.75
- ENTRESTO (Drug) $209.69
- CRESEMBA (Drug) $201.26
- XIFAXAN (Drug) $194.15
- ELIQUIS (Drug) $178.27
- LOKELMA (Drug) $157.20
- DIFICID (Drug) $101.27
- CHANTIX (Drug) $100.75
- JARDIANCE (Drug) $94.87
- Fetroja (Drug) $75.47
- Kcentra (Biological) $74.19
- Veltassa (Drug) $68.04
- PRADAXA (Drug) $62.59
- LANTUS (Drug) $39.93
- RELISTOR (Drug) $34.13
- Yupelri (Drug) $27.16
- BRILINTA (Drug) $23.93
- NOXAFIL (Drug) $22.23
- JYNARQUE (Drug) $21.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Dallas
Dr. Amarinder Bindra
Student in an Organized Health Care Education/Training Program — Payments: $605,555
Ambarish Pandey, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $556,167
Mary Horner, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $256,186
Dr. Allison Dipasquale, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $252,903
Michael Siah
Student in an Organized Health Care Education/Training Program — Payments: $211,953
Young Kwon, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $204,422